P&G board elections
This article was originally published in The Rose Sheet
Executive Summary
A shareholder proposal requesting annual elections of Procter & Gamble's board of directors was approved by a majority (56.2%) of participating voters during the company's Oct. 15 annual shareholder meeting. If adopted, the new scheme would replace the existing system, which involves staggered elections of directors, who are divided into three classes and serve three year terms. CEO A.G. Lafley noted the proposal is "advisory in nature and not binding on the board." The board will, however, take the vote into consideration, he notes. Similar non-binding proposal for Gillette's board of directors was voted on by Gillette shareholders in May (1"The Rose Sheet" May 19, 2003, In Brief)...
You may also be interested in...
Gillette board restructuring
Non-binding proposal to declassify Gillette's board of directors passed by shareholders during May 15 annual meeting. Of the 80% of Gillette shareholders that voted, 64% approved the proposal. Provision would end current system of electing board members to staggered terms by allowing shareholders to vote on entire board each year, ending guaranteed three-year terms. The board, which did not state when it would make a decision on the issue, cautioned against the proposal. It noted a classified board could be "an important part of Gillette's arsenal in resisting a takeover on terms that are not advantageous to all shareholders," according to an April 4 1proxy statement...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.